DEADLINE: AUGUST 10TH @ 12PM ET
TO READ THE LETTER, CLICK HERE
ADAP Advocacy has drafted a letter to the Centers for Medicare and Medicaid Services (CMS) requesting an HIV carve-out exemption for antiretroviral therapies used for the treatment of HIV/AIDS from the agency’s proposed guidance for the Medicare Drug Price Negotiation Program ("Negotiation Program") established under the Inflation Reduction Act of 2022. ADAP Advocacy has requested this carve-out exemption due to the serious nature of the threat facing People Living with HIV/AIDS (PLWHA), should HIV medications be selected as part of the Negotiation Program.
National, state, and local groups are all encouraged to sign this letter. We invite you to sign and circulate this sign-on request to other organizations!
CURRENT SIGNATORIES: (last updated, 08/4/25)